Antibiotics-use in utero and early-life and risk of chronic childhood conditions in New Zealand: a methods protocol using linked data

Author:

Ram Sharan1,Corbin Marine1,Douwes Jeroen1,Kvalsvig Amanda2,Baker Michael G2,Mannetje Andrea1

Affiliation:

1. Massey University

2. University of Otago

Abstract

Abstract

Background The incidence of many common chronic childhood conditions has increased globally in the past few decades. A potential role for antibiotic-(over)-use has been suggested with dysbiosis of the gut microbiome hypothesised to play a key role. This linkage study aims to assess the role of antibiotic-use in utero and in early-life in the development of Type 1 Diabetes (T1D), Attention Deficit Hyperactive Disorder (ADHD) and Inflammatory Bowel Disease (IBD). Methods The study design involves several retrospective cohort studies using linked administrative health and social data from Statistics New Zealand’s Integrated Data Infrastructure. It uses data for all children, and their mothers, born in New Zealand between October 2005 and December 2010 (n = 334,204). Children’s antibiotics-use are identified for four time periods (pregnancy, ≤ 1 year, ≤ 2 years, and ≤ 5 years) and the development of T1D, ADHD, and IBD is measured from the end of the antibiotics-use periods until death, emigration, or the end of the follow-up period (2021), whichever came first. Children who emigrated or died before the end of the antibiotics-use period are excluded. Cox proportional hazards regression models are used whilst adjusting for a range of potential confounders. Discussion These studies, using detailed, complete, and systematically collected antibiotic prescription data, will provide critical new knowledge regarding the role of antibiotics in the development of common chronic childhood conditions. Thus, it has the potential to contribute to the development of primary prevention strategies, through, for example, targeted changes in antibiotic-use.

Publisher

Springer Science and Business Media LLC

Reference39 articles.

1. Comorbidity of inflammatory bowel disease in children and adolescents with type 1 diabetes;Jasser-Nitsche H;Acta Paediatr,2021

2. Estimating the total incidence of type 1 diabetes in children and adolescents aged 0–19 years from 1990 to 2050: a global simulation-based analysis;Ward ZJ;lancet Diabetes Endocrinol,2022

3. Ogle GD, James S, Dabelea D, Pihoker C, Svennson J, Maniam J et al. Global estimates of incidence of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Atlas, 10th edition. Diabetes Research and Clinical Practice. 2022;183:109083.

4. Patterson CC, Karuranga S, Salpea P, Saeedi P, Dahlquist G, Soltesz G et al. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice. 2019;157:107842.

5. Global Incidence of Attention Deficit/Hyperactivity Disorder among Children;Ilic I;Biology Life Sci Forum,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3